Start a hangout
Propeller Health Receives FDA Clearance for the Propeller Platform in Association with Boehringer Ingelheim's Respimat® Inhaler and GlaxoSmithKline's Diskus® Inhaler
FDA-approved marketing claims of "improved adherence" and "reduction in exacerbations" address key unmet needs in respiratory health Madison, WI, July 22, 2015 — Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced U.S. Food and Drug Administration 510(k) clearance to market its Propeller platform in association with medications using
Add a comment...
Financial InstitutionToday Closed
Safeguard Scientifics, Inc. (NYSE:SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on two sectors—healthcare and technology. Specifically, Safeguard targets early- and growth-stage companies in advertising technology, digital media, financial technology, enterprise software, Internet of Things, devices, diagnostics, digital health and healthcare IT.
Write a review
Be the first to review
Upload public photo